TG THERAPEUTICS, INC. Current Liabilities
TG THERAPEUTICS, INC. (TGTX) had Current Liabilities of $268.49 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $268.49M.
- 2026-03-31: Liabilities, Current $187.11M.
- 2025-12-31: Liabilities, Current $153.76M.
- 2025-09-30: Liabilities, Current $156.81M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $268.49M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $187.11M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $153.76M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $156.81M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $171.89M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $160.21M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $90.68M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $125.11M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $108.66M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $99.68M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $53.72M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $57.68M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $72.67M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $63.08M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $53.20M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $36.45M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $43.33M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $54.66M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $65.38M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $87.66M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $87.55M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $92.49M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $87.55M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $77.67M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $67.54M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $63.12M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $84.45M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $80.20M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $55.97M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $60.94M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $38.85M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $40.24M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $36.94M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $33.34M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $27.96M 10-K · filed 2019-03-01 | $27.96M 10-K · filed 2018-03-15 |
| 2017-09-30 | $19.79M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $20.76M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $19.73M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $16.88M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $16.88M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $14.12M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.89M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $10.53M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $9.69M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $9.21M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $9.55M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $5.12M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $8.90M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $2.61M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $1.99M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $6.32M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $5.68M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.47M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $2.47M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $2.22M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $2.96M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.35M 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $1.22M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $1.61M 10-K · filed 2013-03-21 | |
| 2011-09-30 | $1.52M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.78M 10-Q/A · filed 2011-09-14 | |
| 2010-12-31 | $3.29M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |